Exam 3- Lower Respiratory Tract infections (pneumonia) Flashcards

1
Q

Where does the split occur that divides upper respiratory tract infections from lower respiratory tract infections?

A

The split occurs at the neck

Anything above the neck is an URTI
Anything below the neck is a LRTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where does pneumonia typically occur?

A

The alveoli of the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 4 mechanisms of host defense against respiratory tract infections?

A

Nasopharynx
Trachea/Bronchi
Oropharynx
Alveoli/Terminal Airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are examples of nasopharynx host defense mechanisms?

A

These are defenses associated with the nose and areas around the nose

*Nasal hair
-Anatomy of upper airways
-IgA secretion
-Mucociliary Apparatus
-Fibronectin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are examples of trachea/bronchi host defense mechanisms?

A

These are defenses of the trachea and bronchi found in the lungs, they are used to DECREASE BACTERIAL LOAD

*Cough
*Epiglottic reflex (epiglottic closes to prevent aspiration of particles down the trachea)
-Anatomy of conducting airways
-Mucociliary apparatus
-Immunoglobulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are examples of oropharynx host defense mechanisms?

A

These are associated with the mouth

*Saliva
*Slough epithelial cells (shedding, helps get rid of attached bacteria to be removed by the saliva)
-Complement production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are examples of alveoli/terminal airway host defense mechanisms?

A

Found in the lung, these are sites associated with gas exchange. Most defenses are immune-mediated

-Alveolar lining fluid
-Cytokines
-Macrophages +PMNs
-Cell-mediated immunity (B and T cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 4 reasons why host defense mechanisms against a pathogen may not work?

A

-*Pathogen-mediated
(mutations increase ability to infect)

-Host Interventions
(smoking, alcohol)

-Defenses gone wrong
(alveolar amcrophages)

Host disease states
(immunosuppression, etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What host interventions may reduce innate defense mechanisms against pathogens and how do they do this?

A

Smoking- decreases mucociliary apparatus (cilia), increases mucus

Alcohol- decreases epiglottic reflux, increasing likelihood of aspiration

Altered level of consciousness

Endotracheal tubes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What host disease states may decrease innate defense mechanisms against pathogens?

A

*Immunosuppression
-Diabetes
-Asplenia
-Elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the definition of “Community-Acquired Pneumonia”?

A

Pneumonia that developed outside of the hospital OR within 48 hours of hospital admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the most common cause of infection-related hospitalization and mortality?

A

Community Acquired Pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 3 mechanisms of pathogenesis of Community-Acquired Pneumonia?

A

Aspiration
-most common
-common during sleep or in disorders that impair consciousness and depress gag reflex resulting in increased inoculum

Aerosolization
-Direct inhalation of pathogen (virus)
-Droplet nuclei= particles containing pathogen

Bloodborne
-Translocate to pulmonary site
-Uncommon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

I-Clicker: Which microorganism class is the most common pathogenic organism for CAP?
A. Fungus
B. Bacteria
C. Virus
D. Protozoa

A

C. Virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: Viruses normally resolve by themselves and do not require antibiotics

A

True
-although viruses are the most common cause of CAP, we are going to be focusing on the bacterial causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the common bacterial pathogens of CAP?

A

Streptococcus pneumonia (G+)

Haemophilus influenzae (G-)

*Atypical Pathogens:
-Mycoplasma pneumoniae
-Legionella pneumophila
-Chlamydia pneumoniae

Staph aureus (in more serious infections)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the atypical pathogens that are common in CAP?

A

Mycoplasma pneumonia
Legionella pneumophila
Chlamydia pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What 3 drug classes cover atypical pathogens?

A

Fluoroquinolones (“flox”)

Macrolides (“Eryth, Clarith, Azith”)

Tetracyclines (“Tetra, Doxy, Mino”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the typical characteristics of Streptococcus pneumoniae?

A

Increased prevalence + severity in patients with medical condition risk factors (asplenia, diabetes, immunocompromised, etc)

Resistance to penicillins + macrolides is concerning. Risks include:
-Old (>65) or young (<6)
-Prior abx use
-Co-morbid conditions
-Day care
-Recent hospitalization
-Close quarter living

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the typical characteristics of Mycoplasma pneumoniae?

A

Atypical bacteria (not identified on gram stain)

Spread by person-to-person contact (higher risk in close-quarter living)

2-3 week incubation with slow symptom onset

Imaging is more pronounced with patchy, interstitial infiltrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the typical characteristics of Legionella pneumophila?

A

Atypical pathogen

*Found in soil + water

Spread by aerosolization

Risk factors: older males, bronchitis, smokers, immunocompromised

Multisystem involvement is common, leads to more severe symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When it is believed that a CAP patient has a Staph aureus infection, what test needs to be done?

A

MRSA nasal PCR

95-99% negative predictive value for MRSA in CAP
But only 56.8% positive predictive value

*Does a great job of telling you that you do NOT have MRSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the common symptom presentation of CAP?

A

Sudden onset of:
-Fever
-Chills
-Pleuritic chest pain
-Dyspnea
-Productive cough

*Note that Mycoplasma and Chlamydia pneumoniae have a gradual onset and lower severity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the symptom presentation of elderly patients with CAP?

A

Classic symptoms may be absent

*More likely to have decreased functional status, weakness, mental status changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the common vitals of someone with CAP?

A

Febrile
Tachycardic
Hypotensive
Tachypnea (rapid breathing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What diagnostic tests may we run on a patient with CAP?

A

Chest Radiography (Chest X-ray)
*all patients

Sputum Characteristics (Gram stain)

Blood Culture (2 sets)

Respiratory cultures are controversial, only used for severe patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

The appearance of dense lobar consolidation or infiltrates on a Chest x-ray done on a patient with CAP is suspicious for what?

A

Bacterial origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

The appearance of patchy, diffuse, interstitial infiltrates on a Chest X-ray done on a patient with CAP is suspicious for what?

A

Atypical or viral pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

When doing a gram stain, we only evaluate samples that have what?

A

> 25 PMNs
<10 epithelial cells

30
Q

What kind of organism is S. pneumoniae (aka what result on a Gram stain would make us suspicious of this organism)?

A

Gram + Diplococci (pairs/chains)

31
Q

What kind of organism is H. influenzae (aka what result on a Gram stain would make us suspicious of this organism)?

A

Gram - Coccobacilli

(note that Haemophilus species are the only organisms that are classified as coccobacilli)

32
Q

When are respiratory cultures used in CAP?

A

ONLY in severe patients

-note that use is controversial because false negatives are common

33
Q

What are the criteria for diagnosing Severe CAP?

A

Major Criteria (Need 1):
-Septic shock requiring vasopressors
-Respiratory failure requiring mechanical ventilation

Minor Criteria (Need 3 or more):
-Resp Rate >/= 30bpm
-Pa/Fl </= 250 (rare)
-Multilobar infiltrates
-Confusion/disorientation
-Uremia (BUN >/= 20)
-Leukopenia (WBC < 4000)
-Thrombocytopenia (Plt < 100,000)
-Hypothermia (<36C)
-Hypotension requiring aggressive fluids

34
Q

How can getting procalcitonin levels help us in CAP?

A

It is a biomarker typically elevated in bacterial infections

DO NOT USE to determine if antibiotics are needed

Useful to help guide duration of therapy

35
Q

What are the 2 Clinical Prediction Tools that can be used in CAP?

A

Pneumonia Severity Index (PSI)
CURB-65

36
Q

What are the 4 supportive treatment options that can be given to CAP pts?

A

Humidified Oxygen
Bronchodilators
Fluids
Chest Physiotherapy

37
Q

What is the treatment for Empiric Therapy: Outpatient: No Comorbidities?

A

Pick 1:
Amoxicillin (strep pneumo)
Doxycycline (atypical)
Azithromycin (not monotherapy)

38
Q

What is the treatment for Empiric Therapy: Outpatient: With Comorbidities?

A

Monotherapy:
Respiratory Fluoroquinolone (Levofloxacin, Moxifloxacin)

*Combo Therapy:
Beta-Lactam + Macrolide/Doxycycline

preferred beta-lactams:
-Amox/Clav
-Cefpodoxime
-Cefuroxime

39
Q

What is the treatment for Empiric Therapy: Inpatient: Non-Severe CAP: No MRSA/Pseudomonas risks

A

Monotherapy:
Respiratory Fluoroquinolone (Levofloxacin, Moxifloxacin)

Combo Therapy:
Beta-Lactam + Macrolide

preferred beta-lactams:
-Ampicillin/Sulbactam
-Ceftriaxone

*note that doxycycline may be used if FQ or macrolide contraindicated

40
Q

What is the treatment for Empiric Therapy: Inpatient: Severe CAP: No MRSA/Pseudomonas risk factors

A

Combination therapy only:
Respiratory FQ + Beta-lactam
or
Beta-Lactam + Macrolide*

*beta-lactams recommended:
-Ampicillin/Sulbactam
-Ceftriaxone

*note that doxycycline may be used if FQ or macrolide contraindicated

41
Q

What are the Comorbidities that need to be take into consideration for CAP outpatient empiric therapy?

A

Chronic Heart, Lung, or Renal disease
Diabetes
Alcoholism
Malignancy
Asplenia/Immunosuppression

42
Q

What are the risk factors for MRSA?

A

2-14 days post-influenza

Previous MRSA respiratory infection

Previous hospitalization and use of IV abx in last 90 days

43
Q

If a CAP patient needs MRSA coverage, what should we add to their regimen?

A

Vancomycin
or
Linezolid

44
Q

What are the risk factors for Pseudomonas?

A

Previous Pseudomonas respiratory infection

Previous hospitalization and use of IV abx within last 90 days

45
Q

If a CAP patient needs pseudomonas coverage, what should we add to their regimen?

A

Piperacillin/Tazobactam
or
Cefepime
or
Meropenem

46
Q

What is the preferred CAP therapy for Streptococcus pneumoniae?

A

Pen-susc: Penicillin G; Amoxicillin

Pen-resist: Ceftriaxone, Resp FQ

47
Q

What is the preferred CAP therapy for Haemophilus influenzae?

A

2nd/3rd gen cephalosporin
Unasyn
Augmentin

48
Q

What is the preferred CAP therapy for the atypicals: Mycoplasma pneumoniae and Chlamydia pneumoniae?

A

Macrolide
Doxycycline

49
Q

What is the preferred CAP therapy for Legionella pneumophila?

A

FQ

Azithromycin

50
Q

What drug class is not recommended for adults with CAP?

A

Corticosteroids

51
Q

What is the recommended duration of CAP therapy?

A

Need to ensure clinical stability first

Minimum of 5 days

52
Q

How is aspiration pneumonia different than other forms of pneumonia?

A

It is not
-there is no definition to differentiate it against pneumonia

53
Q

If a patient has aspiration pneumonia, what consideration should we make with their treatment?

A

Anaerobic coverage is NOT NEEDED (recommended against)

*unless a lung abscess or empyema (pus development in plural space) is present

54
Q

In what case would both Macrolide and Fluoroquinolone therapy for a CAP patient be contraindicated, pushing the use of Doxycycline instead?

A

Prolonged QTc interval (>460 ish)

55
Q

What is the definition of hospital acquired pneumonia (HAP)?

A

Pneumonia occurring >/= 48 hours after hospital admission

56
Q

What is the definition of ventilator associated pneumonia (VAP)?

A

Pneumonia occurring >/= 48 hours after endotracheal intubation

57
Q

What are the common pathogens in HAP/VAP?

A

Aerobic Gram - Bacilli
-Pseudomonas
Acinetobacter baumannii

Staphylococcus aureus
*MRSA is a greater concern in this population

58
Q

What testing should be conducted in HAP/VAP patients?

A

Respiratory Cultures*
-all patients
-note that this is different from CAP

Blood cultures
-all patients

59
Q

In a respiratory culture for HAP, how many organisms need to be present for it to be considered an infection?

A

10,000
(>/= 10^3)

60
Q

What is the risk factor for developing multi-drug resistant HAP?

A

Prior IV antibiotic use within 90 days

61
Q

What are the risk factors for developing multi-drug resistant VAP?

A

Prior IV antibiotic use within 90 days

Septic shock at time of diagnosis

Acute respiratory distress syndrome prior to diagnosis

Acute renal replacement therapy prior to onset

> /= 5 days of hospitalization prior to diagnosis

62
Q

What is the risk factor for MRSA and Pseudomonas with HAP/VAP?

A

Prior IV antibiotic use within 90 days

63
Q

If a HAP/VAP patient has Pseudomonas, what treatment options could they receive?

A

Carbapenems

Broad-spectrum beta-lactams

Fluoroquinolones

64
Q

What are the risk factors for MRSA with HAP that requires Empiric MRSA Therapy?

A

Prior IV antibiotic use within 90 days

ICUs with > 10-20% MRSA isolates

Treatment where prevalence is unknown

65
Q

What drug choices do we have for MRSA Empiric Therapy in HAP?

A

Vancomycin
Linezolid

66
Q

What are the risk factors for Pseudomonas with HAP that requires Empiric Therapy?

A

Prior IV antibiotic use within 90 days

ICUs with >10% of isolates resistant

Treatment where resistance rates are unknown

67
Q

What drug choices do we have for BOTH Pseudomonas Empiric Therapy AND Patients not at high risk for mortality (no ventilation/ no septic shock) in HAP?

A

Piperacillin-Tazobactam

Cefepime

Imipenem
Meropenem

Levofloxacin

(therapy is the same for both)

68
Q

What drug choices do we have for treatment of High Risk for Mortality (ventilated or have septic shock) with MRSA Risk in HAP?

A

Pick 2 from Different Categories:

Piperacillin-Tazobactam
Cefepime
Imipenem
Meropenem
Levofloxacin
**Tobramycin/Amikacin

(note that this is the same as Pseudomonas and non-high risk except for addition of tobramycin/amikacin and you have to pick 2)

69
Q

What are the therapy options for Empiric VAP Therapy?

A

*Note: choose 2 anti-pseudomonals is risk factors for resistance are present

Otherwise choose one:
-Piperacillin-Tazobactam
Cefepime
-Imipenem
-Meropenem
-Levofloxacin
-Tobramycin/Amikacin

70
Q

What antibiotic should never be used in lower respiratory tract infections (pneumonia)?

A

Daptomycin

-it is inactivated by surfactants

71
Q

What is the typical duration of HAP/VAP therapy?

A

7-day duration if clinically stable